SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Howard Hughes

PatientHoward Hughes
Date of birth1984-12-24
IdentifiersMRN HR-ML006-SYN; SSN (made up) 000-06-5571
Document date2026-09-14
AuthorAnselm Garrity-Moyo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Hughes is a 41-year-old man with obsessive-compulsive disorder on sertraline 200 mg and exposure and response prevention, opioid use disorder on buprenorphine with naloxone, chronic pain after a plane crash, and noise-induced hearing loss with new hearing aids, who comes for his yearly preventive visit three weeks before his twenty-two-week review. He completed the health risk assessment in the waiting room, which he could not have done at intake, and sat in the shared chairs. His washing and checking now take about one and a half hours a day. He has used no opioid other than buprenorphine. He wears his hearing aids every day. He has had no fever or cough since his bronchitis cleared. He cannot recall any vaccines since the crash. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 41
OCDRituals about one and a half hours a day; Y-BOCS 17 today
OpioidsBuprenorphine 8 mg twice daily; no other opioid use
MoodPHQ-2 0
MedicinesSertraline 200 mg daily; buprenorphine with naloxone 8 mg twice daily; acetaminophen 1,000 mg three times daily; naloxone nasal spray on hand

Health risk assessment. Completed on paper in the waiting room and reviewed with the patient by Dr. Garrity-Moyo. [S]

DomainFinding
Self-rated healthGood, and better than in the spring
PsychosocialWeekly exposure therapy; working longer days; still prefers to meet few people
Substance useIn treatment for opioid use disorder on buprenorphine; AUDIT-C 1 at intake
TobaccoNever smoked
Physical activityPhysical therapy exercises daily and walks most days
NutritionThree meals a day, including food his cook prepares without his watching
SleepSix to seven hours
Safety at homeFeels safe; no firearms in the home; naloxone in the house
Road and air safetyWears a seat belt; wears hearing protection when flying
Activities of daily livingIndependent
Hearing and visionHearing aids daily; no vision problems

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or night sweats; weight rising as planned
EyesNegativeNo vision change
Ears, nose, mouth, and throatPositiveHearing loss, helped by hearing aids; no tinnitus or ear pain
CardiovascularNegativeNo chest pain apart from the old chest wall pain, no palpitations
RespiratoryNegativeCough resolved; no shortness of breath
GastrointestinalNegativeNo constipation on buprenorphine; no blood in the stool
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalPositiveChest wall, left shoulder and low back pain, milder than in the spring
SkinNegativeHands no longer cracked from washing
NeurologicalNegativeNo headaches, weakness or numbness
PsychiatricPositiveContamination fears milder; mood good; no thoughts of suicide or of harming anyone

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a dayOne or two tablets every 6 hours as needed, no more than 8 a dayOral route2026-05-04 to 2026-05-11completedS
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staffOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route2026-05-04activeS
Buprenorphine 2 mg with naloxone 0.5 mg sublingual film for the first day: 4 mg once withdrawal is moderate (COWS 12 or more), then 2 to 4 mg every one to two hours as needed, to no more than 16 mg on the first dayFirst-day induction by the written plan, no more than 16 mgSublingual route2026-05-11 to 2026-05-12completedS
Buprenorphine 8 mg with naloxone 2 mg sublingual film, one film twice daily (16 mg a day), for opioid use disorder and pain; dispensed one week at a time at firstOne film under the tongue twice dailySublingual route2026-05-12activeS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain after the crash, now that codeine combination tablets have stoppedTwo tablets three times daily, no more than 3,000 mg a dayOral route2026-05-11activeS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-05-11 to 2026-06-08completedS
Sertraline 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-08 to 2026-07-13completedS
Sertraline 100 mg oral tablet, two tablets daily (200 mg), the usual target range for OCDTwo tablets dailyOral route2026-07-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-14Body height191cmS
2026-09-14Body weight75.6kgS
2026-09-14Body mass index (BMI) [Ratio]20.7kg/m2S
2026-09-14Systolic blood pressure116mm[Hg]S
2026-09-14Diastolic blood pressure74mm[Hg]S
2026-09-14Heart rate70/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-14Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
2026-09-14Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
2026-09-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-09-14Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS
2026-09-14Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 75.6 kg, BMI 20.7; blood pressure 116/74; pulse 70
Ears, nose, mouth, and throatHearing aids in place; canals clear; teeth and gums healthy
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation; healed scars on the chest wall
AbdomenSoft and non-tender
SkinHealed burn scars; hands no longer cracked
PsychiatricCalm and engaged; shook hands at the end of the visit

Problems

ProblemClinical statusVerificationCodeProvenance
Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluationresolvedconfirmed R46.81S — Synthetic presenting problem anchored to his documented fear of germs; resolved into the diagnosis of OCD at the consultation. Not a claim about his real symptoms in 1947.
Obsessive-compulsive disorder, contamination type, with good or fair insight, not tic-related; Y-BOCS 28 (severe) at intake; no post-traumatic stress disorder on screeningactiveconfirmed F42.2S — Synthetic modern diagnosis made at the consultation, linked to the retrospective interpretation of his documented fears (R). Not a claim about his real diagnosis.
Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine plannedactiveconfirmed F11.20S — Synthetic modern coding; tolerance and withdrawal are not counted for a medicine taken under medical supervision. Person-first language; not a claim about his real diagnosis.
Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7activeconfirmed G89.21S — Synthetic modern diagnosis anchored to his documented injuries.
Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluationresolvedconfirmed H91.93S — Synthetic presenting problem; resolved into a diagnosis when audiometry was done at five weeks. His documented deafness is from later years.
Bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz, consistent with noise exposure from flying; hearing aids fittedactiveconfirmed H90.3S — Synthetic modern diagnosis made at five weeks; not a claim about his real hearing in 1947.
Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fearsactiveconfirmed R63.4S — Synthetic nutrition problem linked to the contamination fears; not a claim about his real weight in 1947.
Acute bronchitis, likely viral, for five days; no pneumonia on examination; resolved within three weeks without antibioticsresolvedconfirmed J20.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressureCompleted today116/74 mmHg
Lipid screening and cardiovascular riskCompleted todayLDL 112 mg/dL; low 10-year risk; statin not indicated
Diabetes screeningNot indicatedRecommended for adults 35 to 70 with overweight or obesity; his BMI is 20.7
Colorectal cancer screeningNot indicatedBegins at 45; no family history recorded
Lung cancer screeningNot indicatedNever smoked
HIV screeningUp to dateNegative at intake
Hepatitis C screeningUp to dateAntibody negative at intake
Hepatitis B screeningUp to dateTriple panel at intake: not infected and not immune
Depression screeningCompleted todayPHQ-2 0
Unhealthy drug useUp to dateIn treatment for opioid use disorder
Unhealthy alcohol useUp to dateAUDIT-C 1 at intake; advised to keep alcohol low with buprenorphine
HearingUp to dateAudiogram at five weeks; hearing aids fitted at ten weeks
Influenza vaccineCompleted todayVaccine for the coming season given today
Tetanus, diphtheria, and pertussisCompleted todayTdap today; no booster recorded since the crash
Hepatitis B vaccineCompleted todayFirst of two HepB-CpG doses; second in one month or more
COVID-19 vaccineDueRecommended for the coming season; he chose to have it at his next visit rather than a fourth injection today

Immunizations given today: Influenza vaccine for the coming season; Tdap vaccine; no tetanus booster recorded since the crash; Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake [S]

Guideline basis: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Twenty-two-week review in three weeks with laboratory tests. Second hepatitis B dose in one month or more; COVID-19 vaccine at the next visit. Next preventive visit in one year. Next scheduled visit 2026-10-05: twenty-two-week review: response of OCD, buprenorphine maintenance, pain, weight and laboratory checks. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 16 minutes, with his consent. He named a health care agent and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is privacy, being able to work, and making his own decisions. He would want full treatment for any condition from which he could recover and to be told plainly about his health. He chose not to record other preferences today. The plan will be revisited yearly or after any serious illness or injury. [S]